Dara Stein

487 total citations
17 papers, 346 citations indexed

About

Dara Stein is a scholar working on Oncology, Epidemiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Dara Stein has authored 17 papers receiving a total of 346 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Epidemiology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Dara Stein's work include Inflammatory Bowel Disease (3 papers), Microscopic Colitis (3 papers) and Health Systems, Economic Evaluations, Quality of Life (3 papers). Dara Stein is often cited by papers focused on Inflammatory Bowel Disease (3 papers), Microscopic Colitis (3 papers) and Health Systems, Economic Evaluations, Quality of Life (3 papers). Dara Stein collaborates with scholars based in United States, United Kingdom and Netherlands. Dara Stein's co-authors include Joung H. Lee, Dennis W. Stacey, Sam E. Kinney, Andrés Yarur, Mark S. Silverberg, Emanuelle Bellaguarda, Uri Kopylov, Spyridon Michopoulos, David T. Rubin and Jesse Siffledeen and has published in prestigious journals such as Gastroenterology, Cancer and Neurosurgery.

In The Last Decade

Dara Stein

16 papers receiving 342 citations

Peers

Dara Stein

EPIDE

GENET

ONCOL

PRM

Snežana Živković Serbia

Caterina Baldi Italy

Ivana Nikolić Serbia

Martin H. Huber United States

Khalid M. Al-Harbi Saudi Arabia

Erin Carter United States

Hiroo Imai Japan

Yiying Guo China

Snežana Živković Serbia

Dara Stein

49 ×0.4

EPIDE

29 ×0.3

GENET

157 ×1.9

ONCOL

30 ×0.5

PRM

87 ×1.5

Citations per year, relative to Dara Stein Dara Stein (= 1×) peers Snežana Živković

Countries citing papers authored by Dara Stein

Since Specialization

Citations

This map shows the geographic impact of Dara Stein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dara Stein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dara Stein more than expected).

Fields of papers citing papers by Dara Stein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dara Stein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dara Stein. The network helps show where Dara Stein may publish in the future.

Co-authorship network of co-authors of Dara Stein

This figure shows the co-authorship network connecting the top 25 collaborators of Dara Stein. A scholar is included among the top collaborators of Dara Stein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dara Stein. Dara Stein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Zeitler, Emily P., et al.. (2025). Health Care Resource Utilization With Dronedarone Versus Sotalol Following Catheter Ablation in Adults With Atrial Fibrillation. Clinical Cardiology. 48(1). e70064–e70064.

Carroll, Robert, Dara Stein, Delphine Saragoussi, et al.. (2021). Nivolumab in Gastric/Gastroesophageal Junction Cancer: Real-World Data from UK Early Access to Medicines Scheme. Future Oncology. 17(24). 3163–3174. 3 indexed citations

Bressler, Brian, Andrés Yarur, Mark S. Silverberg, et al.. (2021). Vedolizumab and Anti-Tumour Necrosis Factor α Real-World Outcomes in Biologic-Naïve Inflammatory Bowel Disease Patients: Results from the EVOLVE Study. Journal of Crohn s and Colitis. 15(10). 1694–1706. 95 indexed citations

Atkinson, Victoria, Shahneen Sandhu, Geke A.P. Hospers, et al.. (2020). Dabrafenib plus trametinib is effective in the treatment of BRAF V600-mutated metastatic melanoma patients: analysis of patients from the dabrafenib plus trametinib Named Patient Program (DESCRIBE II). Melanoma Research. 30(3). 261–267. 25 indexed citations

Helwig, Ulf, Michael Mroß, Stefan Schubert, et al.. (2020). Real-world clinical effectiveness and safety of vedolizumab and anti-tumor necrosis factor alpha treatment in ulcerative colitis and Crohn’s disease patients: a German retrospective chart review. BMC Gastroenterology. 20(1). 211–211. 28 indexed citations

Boye, Kristina S., Dara Stein, Louis S. Matza, et al.. (2019). Timing of GLP-1 Receptor Agonist Initiation for Treatment of Type 2 Diabetes in the UK. Drugs in R&D. 19(2). 213–225. 13 indexed citations

Wang, Meng, et al.. (2019). Early Access to Medicines Scheme: real-world data collection. Drug Discovery Today. 24(12). 2231–2233. 4 indexed citations

McDonald, Laura, Dara Stein, Robert Carroll, et al.. (2019). Extracting Data from a Chemotherapy Prescription Platform for Real-World Oncology Research in the UK: A Pilot Study. Future Oncology. 15(21). 2471–2477. 4 indexed citations

Yarur, Andrés, Gerassimos J. Mantzaris, Mark S. Silverberg, et al.. (2019). Su1858 – Real-World Effectiveness and Safety of Vedolizumab and Anti-TNF in Biologic-Naive Ulcerative Colitis Patients: Results from the Evolve Study. Gastroenterology. 156(6). S–637. 1 indexed citations

10.

Hirsch, Fred R., Lecia V. Sequist, Ira Gore, et al.. (2018). Long‐term safety and survival with gefitinib in select patients with advanced non–small cell lung cancer: Results from the US IRESSA Clinical Access Program (ICAP). Cancer. 124(11). 2407–2414. 15 indexed citations

11.

Srinivas, Sandy, et al.. (2017). Real-world chart review study of adverse events management in patients taking tyrosine kinase inhibitors to treat metastatic renal cell carcinoma. Journal of Oncology Pharmacy Practice. 24(8). 574–583. 16 indexed citations

12.

Gelderblom, Hans, Ian Judson, Charlotte Benson, et al.. (2017). Treatment patterns and clinical outcomes with pazopanib in patients with advanced soft tissue sarcomas in a compassionate use setting: results of the SPIRE study. Acta Oncologica. 56(12). 1769–1775. 32 indexed citations

13.

Stein, Dara, et al.. (2014). Assessing health-state utility values in patients with metastatic colorectal cancer: a utility study in the United Kingdom and the Netherlands. International Journal of Colorectal Disease. 29(10). 1203–1210. 21 indexed citations

14.

Lee, Joung H., et al.. (1997). Reduced Expression of Schwannomin/Merlin in Human Sporadic Meningiomas. Neurosurgery. 40(3). 578–587. 44 indexed citations

15.

Lee, Joung H., et al.. (1997). Reduced Expression of Schwannomin/Merlin in Human Sporadic Meningiomas. Neurosurgery. 40(3). 578–587. 3 indexed citations

16.

Stein, Dara. (1964). Über ein neues Verfahren zur Ermittlung des Verzweigungsgrades eines Polymeren bei Radikalpolymerisation. Die Makromolekulare Chemie. 76(1). 157–169. 12 indexed citations

17.

Stein, Dara. (1964). Über die Verzweigung des Polyvinylacetats. III. Bestimmung des Verzweigungsgrades und reaktionskinetischer Konstanten durch Messung der Mittelwerte des Polymerisationsgrades P_w und P_n als Funktion des Umsatzes. Die Makromolekulare Chemie. 76(1). 170–182. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact